Indian team uses repurposed drug to treat oral cancer subtype
A study by Mumbai-based researchers has successfully identified a novel fusion transcript in head and neck cancer patients. Not only did the researchers find the fusion transcript to be a promising therapeutic target for head and neck cancer but also found that an FDA-approved deworming drug called pyrvinium pamoate can be a potential drug to…
Read More “Indian team uses repurposed drug to treat oral cancer subtype” »